Dynavax Technologies Corp (DVAX)

4.03
0.13 3.00
NASDAQ : Health Care
Prev Close 4.15
Open 4.15
Day Low/High 3.95 / 4.16
52 Wk Low/High 12.84 / 32.49
Volume 678.54K
Avg Volume 1.95M
Exchange NASDAQ
Shares Outstanding 38.53M
Market Cap 163.74M
EPS -3.20
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

DEADLINE ALERT: Brower Piven Reminds Investors Of The January 17, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess Of $100,000 From Investment In Dynavax Technologies Corporation To Contact The Firm

DEADLINE ALERT: Brower Piven Reminds Investors Of The January 17, 2017 Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess Of $100,000 From Investment In Dynavax Technologies Corporation To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf...

My Top 2017 Pick: Progenics Pharmaceuticals

My Top 2017 Pick: Progenics Pharmaceuticals

This biopharma company's Relistor drug should send revenues sharply higher this year.

Top 2017 Pick: Progenics Pharmaceuticals

Top 2017 Pick: Progenics Pharmaceuticals

This biopharma company's Relistor drug should send revenues sharply higher next year.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Dynavax Technologies Corporation Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 17, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders Of Dynavax Technologies Corporation Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of January 17, 2017

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Dynavax Technologies Corporation (NASDAQ:DVAX) between March 10,...

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016

TheStreet's biotech columnist offers his own report card on biotech stocks.

DVAX SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Dynavax Technologies Corporation And A Lead Plaintiff Deadline Of January 17, 2017

DVAX SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of Commencement Of A Class Action Involving Dynavax Technologies Corporation And A Lead Plaintiff Deadline Of January 17, 2017

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Northern District of California on behalf of investors who purchased Dynavax Technologies Corporation (NASDAQ:...

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Dynavax Technologies Corporation Investors And Encourages Investors To Contact The Firm

The Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Dynavax Technologies Corporation Investors And Encourages Investors To Contact The Firm

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Dynavax Technologies Corporation ("Dynavax" or the "Company") (NASDAQ: DVAX) securities...

The Worst Biopharma CEOs of 2016 Are ...

The Worst Biopharma CEOs of 2016 Are ...

There was plenty of shame to spread around, but Theranos CEO Elizabeth Holmes' loathsome mix of arrogance, incompetence and duplicity makes her the Worst CEO of 2016.

5 Stocks Poised for Major Breakouts--Gold, Pharma and Tech

5 Stocks Poised for Major Breakouts--Gold, Pharma and Tech

These stocks are within range of triggering breakout trades. Here's how to trade them from here.

Oversold Conditions For Dynavax Technologies (DVAX)

Oversold Conditions For Dynavax Technologies (DVAX)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

INVESTOR ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against Dynavax Technologies Corporation And Encourages Investors With Losses To Contact The Firm

INVESTOR ALERT: Goldberg Law PC Announces The Filing Of A Securities Class Action Lawsuit Against Dynavax Technologies Corporation And Encourages Investors With Losses To Contact The Firm

Goldberg Law PC, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Dynavax Technologies Corporation ("Dynavax" or the "Company") (Nasdaq: DVAX).

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Dynavax Technologies Corporation

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Dynavax Technologies Corporation

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Dynavax Technologies Corporation securities (NASDAQ:DVAX) from March 10, 2014 through November 11,...

Dow Scores Slim New Record While Nasdaq, S&P 500 Fall

Dow Scores Slim New Record While Nasdaq, S&P 500 Fall

The Dow ekes out slim gains to score a new record on Monday.

Stocks Waver as Wall Street's Trump Rally Fades

Stocks Waver as Wall Street's Trump Rally Fades

Stocks hold mixed midday Monday as Wall Street continues to pick apart the likely policies of President-elect Donald Trump.

Dynavax Shares Plunge on Rejected Application

Dynavax Shares Plunge on Rejected Application

Shares of the drugmaker were falling on news that U.S. regulators have rejected its Heplisav-B application

How to Trade Monday's Most Active Stocks - Facebook, Dynavax, Barrick Gold, More

How to Trade Monday's Most Active Stocks - Facebook, Dynavax, Barrick Gold, More

Here's a technical look at how to trade some of the most active stocks on the market right now.

Midday Report: Dynavax Slumps on FDA Rejection; U.S. Stocks Fluctuate

Midday Report: Dynavax Slumps on FDA Rejection; U.S. Stocks Fluctuate

U.S. stocks fluctuate as Wall Street picks apart the likely policies of President-elect Donald Trump.

Noteworthy Monday Option Activity: DVAX, GLPI, HRTX

Noteworthy Monday Option Activity: DVAX, GLPI, HRTX

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Dynavax Technologies Corp , where a total volume of 15,765 contracts has been traded thus far today, a contract volume which is representative of approximately 1.6 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 168.2% of DVAX's average daily trading volume over the past month, of 937,270 shares.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Dynavax Technologies Corporation

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces The Commencement Of An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Dynavax Technologies Corporation

Levi & Korsinsky announces it has commenced an investigation of Dynavax Technologies Corporation ("Dynavax" or the "Company") (NASDAQ: DVAX) concerning possible violations of federal securities laws by certain officers...

Stocks Fluctuate as Wall Street Picks Apart Trump's Policies

Stocks Fluctuate as Wall Street Picks Apart Trump's Policies

Stocks hold mixed on Monday as Wall Street continued to pick apart the likely policies of President-elect Donald Trump.

Dynavax Shares Fall on FDA Rejection of Hepatitis B Vaccine

Dynavax Shares Fall on FDA Rejection of Hepatitis B Vaccine

Dynavax now says it will need assistance from another drug company or financial partner to resubmit Heplisav-B for another shot at approval.

Dynavax Technologies Stock Sees Short Interest Increase 10.3%

Dynavax Technologies Stock Sees Short Interest Increase 10.3%

The most recent short interest data has been released for the 10/31/2016 settlement date, which shows a 1,081,158 share increase in total short interest for Dynavax Technologies Corp , to 11,523,545, an increase of 10.35% since 10/14/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

Notable Wednesday Option Activity: DVAX, GTY, ENH

Notable Wednesday Option Activity: DVAX, GTY, ENH

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Dynavax Technologies Corp , where a total volume of 9,981 contracts has been traded thus far today, a contract volume which is representative of approximately 998,100 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 50% of DVAX's average daily trading volume over the past month, of 2.0 million shares.